101 related articles for article (PubMed ID: 15446311)
1. Donor-derived, liver-specific protein expression after bone marrow transplantation.
Jenkins DD; Streetz K; Tataria M; Sahar D; Kurobe M; Longaker MT; Kay MA; Sylvester KG
Transplantation; 2004 Aug; 78(4):530-6. PubMed ID: 15446311
[TBL] [Abstract][Full Text] [Related]
2. Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells.
Streetz KL; Doyonnas R; Grimm D; Jenkins DD; Fuess S; Perryman S; Lin J; Trautwein C; Shizuru J; Blau H; Sylvester KG; Kay MA
Hepatology; 2008 Feb; 47(2):706-18. PubMed ID: 18220289
[TBL] [Abstract][Full Text] [Related]
3. Hepatic injury and the kinetics of bone marrow-derived hepatocyte transgene expression.
Perryman SV; Jenkins DD; Streetz KL; Longaker MT; Sylvester KG
J Pediatr Surg; 2008 Aug; 43(8):1511-9. PubMed ID: 18675644
[TBL] [Abstract][Full Text] [Related]
4. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
Schowalter DB; Himeda CL; Winther BL; Wilson CB; Kay MA
J Virol; 1999 Jun; 73(6):4755-66. PubMed ID: 10233936
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin.
Li H; Lu Y; Witek RP; Chang LJ; Campbell-Thompson M; Jorgensen M; Petersen B; Song S
Mol Ther; 2010 Aug; 18(8):1553-8. PubMed ID: 20551917
[TBL] [Abstract][Full Text] [Related]
6. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.
Pastore L; Morral N; Zhou H; Garcia R; Parks RJ; Kochanek S; Graham FL; Lee B; Beaudet AL
Hum Gene Ther; 1999 Jul; 10(11):1773-81. PubMed ID: 10446917
[TBL] [Abstract][Full Text] [Related]
7. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors.
Schiedner G; Hertel S; Johnston M; Dries V; van Rooijen N; Kochanek S
Mol Ther; 2003 Jan; 7(1):35-43. PubMed ID: 12573616
[TBL] [Abstract][Full Text] [Related]
8. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.
Ponder KP; Gupta S; Leland F; Darlington G; Finegold M; DeMayo J; Ledley FD; Chowdhury JR; Woo SL
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1217-21. PubMed ID: 1899924
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
[TBL] [Abstract][Full Text] [Related]
10. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.
Park F; Ohashi K; Kay MA
Mol Ther; 2003 Aug; 8(2):314-23. PubMed ID: 12907154
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation results in donor-derived hepatocytes in an animal model of inherited cholestatic liver disease.
Chen HL; Wang R; Chen HL; Hwu WL; Jeng YM; Chang MH; Ling V
J Biomed Sci; 2008 Sep; 15(5):615-22. PubMed ID: 18509747
[TBL] [Abstract][Full Text] [Related]
12. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
Van Linthout S; Lusky M; Collen D; De Geest B
Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
[TBL] [Abstract][Full Text] [Related]
13. Liver-directed gene therapy: evaluation of liver specific promoter elements.
Hafenrichter DG; Ponder KP; Rettinger SD; Kennedy SC; Wu X; Saylors RS; Flye MW
J Surg Res; 1994 Jun; 56(6):510-7. PubMed ID: 8015304
[TBL] [Abstract][Full Text] [Related]
14. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of Adipose Tissue-Derived Mesenchymal Stem Cell (ATMSC) Expressing Alpha-1 Antitrypsin Reduces Bone Loss in Ovariectomized Osteoporosis Mice.
Akbar MA; Lu Y; Elshikha AS; Chen MJ; Yuan Y; Whitley EM; Holliday LS; Chang LJ; Song S
Hum Gene Ther; 2017 Feb; 28(2):179-189. PubMed ID: 27802778
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes.
Kay MA; Graham F; Leland F; Woo SL
Hepatology; 1995 Mar; 21(3):815-9. PubMed ID: 7875680
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.
Yoshida Y; Hirano T; Son G; Iimuro Y; Imado T; Iwasaki T; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1114-23. PubMed ID: 17761834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
